Recurrent respiratory papillomatosis: current and future perspectives

M Carifi, D Napolitano, M Morandi… - … and clinical risk …, 2015 - Taylor & Francis
Although recurrent respiratory papillomatosis is a benign disease of the upper aerodigestive
tract caused by infection with human papillomavirus, the disease process is unpredictable …

Current and future management of recurrent respiratory papillomatosis

R Ivancic, H Iqbal, B deSilva, Q Pan… - Laryngoscope …, 2018 - Wiley Online Library
Objectives Recurrent respiratory papillomatosis (RRP) is a chronic disease of the respiratory
tract that occurs in both children and adults. It is caused by the human papillomavirus (HPV) …

Systemic bevacizumab for recurrent respiratory papillomatosis: a national survey

SR Best, M Mohr, KB Zur - The Laryngoscope, 2017 - Wiley Online Library
Objectives/Hypothesis Aggressive laryngeal, tracheal, and pulmonary papilloma is an
extremely challenging clinical problem without proven treatment options. A recent German …

Recurrent respiratory papillomatosis: a 2020 perspective

JJ Benedict, CS Derkay - Laryngoscope investigative …, 2021 - Wiley Online Library
Objective Despite recent advancement recurrent respiratory papillomatosis (RRP) remains a
rare but challenging benign airway neoplasm. In recent years there has been significant …

Systemic bevacizumab for treatment of respiratory papillomatosis: international consensus statement

DR Sidell, K Balakrishnan, SR Best, K Zur… - The …, 2021 - Wiley Online Library
Objectives/Hypothesis The purpose of this study is to develop consensus on key points that
would support the use of systemic bevacizumab for the treatment of recurrent respiratory …

High-dose sublesional bevacizumab (avastin) for pediatric recurrent respiratory papillomatosis

DR Sidell, M Nassar, RT Cotton… - Annals of Otology …, 2014 - journals.sagepub.com
Objectives: We review and report the use of high-dose bevacizumab for the treatment of
recurrent respiratory papillomatosis (RRP) in pediatric patients. Methods: We included all …

Long‐term follow‐up of parenteral bevacizumab in patients with recurrent respiratory papillomatosis

SA Ballestas, J Hidalgo Lopez, AM Klein… - The …, 2023 - Wiley Online Library
Objective The clinical course of recurrent respiratory papillomatosis (RRP) varies from
spontaneous remission to severe airway obstruction with wide variability in recurrence …

Trends in recurrent respiratory papillomatosis treatment

SA Ballestas, S Shelly, RM Soriano, A Klein - Acta Otorrinolaringologica …, 2021 - Elsevier
Recurrent respiratory papillomatosis (RRP) consist of benign tumours along the airway
caused by human papillomavirus infection. Papillomas may cause changes in phonation …

[HTML][HTML] Systemic bevacizumab for recurrent respiratory papillomatosis: a single center experience of two cases

A Bedoya, K Glisinski, J Clarke, RN Lind… - The American Journal …, 2017 - ncbi.nlm.nih.gov
Objective: Unusual clinical course Background: Recurrent respiratory papillomatosis (RRP),
caused by human papillomavirus (HPV), is the most common benign neoplasm of the larynx …

Intralesional cidofovir vs. bevacizumab for recurrent respiratory papillomatosis: a systematic review and indirect meta-analysis

FH Zagzoog, AM Mogharbel, A Alqutub… - European Archives of …, 2024 - Springer
Background Specific HPV types cause recurrent respiratory papillomatosis (RRP). When
administered intralesionally, cidofovir, an antiviral agent, has shown favorable outcomes in …